BCAX
Price
$18.17
Change
+$1.02 (+5.95%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
949.37M
Intraday BUY SELL Signals
BMRN
Price
$54.30
Change
+$0.41 (+0.76%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
10.57B
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAX vs BMRN

Header iconBCAX vs BMRN Comparison
Open Charts BCAX vs BMRNBanner chart's image
Bicara Therapeutics
Price$18.17
Change+$1.02 (+5.95%)
Volume$7.05K
Capitalization949.37M
BioMarin Pharmaceutical
Price$54.30
Change+$0.41 (+0.76%)
Volume$54K
Capitalization10.57B
BCAX vs BMRN Comparison Chart in %
BCAX
Daily Signal:
Gain/Loss:
BMRN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BCAX vs. BMRN commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAX is a StrongBuy and BMRN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (BCAX: $17.16 vs. BMRN: $53.89)
Brand notoriety: BCAX and BMRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAX: 24% vs. BMRN: 27%
Market capitalization -- BCAX: $949.37M vs. BMRN: $10.57B
BCAX [@Biotechnology] is valued at $949.37M. BMRN’s [@Biotechnology] market capitalization is $10.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAX’s FA Score shows that 1 FA rating(s) are green whileBMRN’s FA Score has 0 green FA rating(s).

  • BCAX’s FA Score: 1 green, 4 red.
  • BMRN’s FA Score: 0 green, 5 red.
According to our system of comparison, BCAX is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAX’s TA Score shows that 5 TA indicator(s) are bullish while BMRN’s TA Score has 5 bullish TA indicator(s).

  • BCAX’s TA Score: 5 bullish, 5 bearish.
  • BMRN’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than BCAX.

Price Growth

BCAX (@Biotechnology) experienced а -7.04% price change this week, while BMRN (@Biotechnology) price change was -4.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

BMRN is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.6B) has a higher market cap than BCAX($949M). BMRN has higher P/E ratio than BCAX: BMRN (20.46) vs BCAX (3.22). BCAX YTD gains are higher at: -1.493 vs. BMRN (-18.013). BMRN has higher annual earnings (EBITDA): 934M vs. BCAX (-121M). BMRN has more cash in the bank: 1.43B vs. BCAX (437M). BCAX has less debt than BMRN: BCAX (2.24M) vs BMRN (604M). BMRN has higher revenues than BCAX: BMRN (3.06B) vs BCAX (0).
BCAXBMRNBCAX / BMRN
Capitalization949M10.6B9%
EBITDA-121M934M-13%
Gain YTD-1.493-18.0138%
P/E Ratio3.2220.4616%
Revenue03.06B-
Total Cash437M1.43B31%
Total Debt2.24M604M0%
FUNDAMENTALS RATINGS
BMRN: Fundamental Ratings
BMRN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
64
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCAXBMRN
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
69%
Momentum
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
58%
MACD
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
53%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 9 days ago
58%
Declines
ODDS (%)
Bearish Trend 29 days ago
90%
Bearish Trend 14 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BCAX
Daily Signal:
Gain/Loss:
BMRN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JGIRX101.14N/A
N/A
JPMorgan U.S. GARP Equity R5
VSCAX26.69N/A
N/A
Invesco Small Cap Value A
MPAIX28.00N/A
N/A
Morgan Stanley Inst Advantage I
LGOVX36.59N/A
N/A
Lord Abbett Growth Opportunities R6
ISGNX17.58N/A
N/A
Columbia Integrated Small Cap Gr Instl

BCAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAX has been loosely correlated with KURA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAX jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAX
1D Price
Change %
BCAX100%
-0.98%
KURA - BCAX
42%
Loosely correlated
-2.53%
IMNM - BCAX
41%
Loosely correlated
-6.71%
SYRE - BCAX
41%
Loosely correlated
-0.91%
BMRN - BCAX
39%
Loosely correlated
-2.07%
ORKA - BCAX
39%
Loosely correlated
+0.56%
More

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with TECH. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-2.07%
TECH - BMRN
55%
Loosely correlated
-1.32%
BEAM - BMRN
48%
Loosely correlated
-2.83%
SYRE - BMRN
47%
Loosely correlated
-0.91%
JAZZ - BMRN
45%
Loosely correlated
-3.17%
IRON - BMRN
45%
Loosely correlated
-2.16%
More